A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

Clinical trial NCT02756247 · COMPLETED

Trial details

NCT number: NCT02756247
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B Cell Lymphoma

Start date: 2016-05-09
Primary completion: 2022-10-06
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.